Narrative Synthesis of Reviewed Evidence
Maternal Outcomes Associated with Caesarean Section Delivery
The evidence reviewed showed that CSD in LMICs is associated with a range of maternal health complications. Considering mental health-related outcomes, one prospective cohort study conducted in private institutions found that 11.2% of post elective-CSD postpartum depressive symptoms, 5.6% before and after childbirth and 5.6% after childbirth [63]. Two studies discussed postpartum-related infection. Rwabizi et al. outlined a prevalence of 83% of maternal morbidity associated with postpartum infection in a sample of public and private facilities [43]. More specifically, Sharma and Dhakal found an incidence of surgical site infections (SSI) of 7.6% [54].
Likewise, for Chu et al., this was 7.3% (range 1.7–10.4%) in the DRC, Burundi and Sierra Leone [42]. For public institutions, the surgical site infection SSI incidence was 23.5% (95% diagnosed within the two weeks following discharge) in Del Monte and Neto’s study [56]. However, in Nepal, undergoing a CSD in public hospitals led to a significantly lower prevalence of SSI (3.8%), but the most prevalent was postpartum hemorrhage (30.5%), followed by injury to the surrounding structure (19.2%) [49]. Sharma & Dhakal found greater prevalence in low segment CSD (53.5% vs. 39%; χ 2 = 9.11, p <0.05) [54]. Cisse et al., in their mix of private facilities in Senegal, contended with a CSD-related maternal mortality and morbidity at 3.3% versus 13.85 (with indication), 2.6% vs. 3.8% (discretion), 3.7% vs. 14.6% (essential) p <10–8 [44]. In a panel study analyzing a time trend CSD (2000 to 2011) at the Muhimbili National Hospital in Dar es Salaam, Tanzania, Litorp et al. found an increase in the maternal mortality ratio from 463/100,000 live births to 650/100,000 (p = 0.031) [46]. Lumbiganon et al.’s Asian wide cross-sectional study, which randomly selected 122 private and public facilities, found an important risk associated to CSD [53]. Compared to spontaneous delivery, antepartum CSD with indication was increased (adjusted odds ratio [aOR] = 1.1, 0.5–2.3). The risk was even greater during the intrapartum stage: aOR = 4.8 (95%CI = 0.6 – 36,5) (without indication) and aOR = 1.6 (95%CI = 0.9 – 2.8) (with indication) [53].
In dealing with urinary incontinence (UI) in public institutions, Borges et al. [41] found that the burden was borne more by mothers who underwent normal vaginal delivery (VD) for either mixed UI (OR = 8.53, 95% CI = 1.25–364.12) or stress UI (OR = 9.07, 95% CI = 1.34–385.56) than for CSD: mixed UI (OR = 7.3, 95% CI = 0.83–341.94) and stress UI (OR = 2.43, 95% CI = 0.12–146.16). Similarly, Kavosi et al. [51] highlighted a low postpartum quality of life (QOL) (mental health score, SF–36) for CS delivery (56.05±11.97) compared to normal VD (60.17±18.76) and water birth (61.41±11.16), but the difference was not significant (p = 0.247). Silva et al.’s research in aggregating public and private facilities in a cross-sectional study of 2,434 singleton live births found that mothers who underwent CSD (33.7%) show an increased risk of low birth weight (LBW) (OR 1.58, 95% CI 1.09–2.26) [61]. One study focused on the incidence of maternal near – miss events during hospitalization for childbirth care. Mixing both public and private providers, it appears that compared to VD, maternal near-miss events associated with elective CSD were significantly (p <0.001) greater (AOR = 2.54, 95%CI 1.67–3.88) than those with intrapartum CSD (AOR = 1.05, 95%CI 0.54–2.03) [57].
Neonatal Outcomes Associated with CSD
Over the perinatal period, Litorp et al.’s time trend analysis of CSD (2001 to 2011) found an increase in perinatal mortality (p = 0.381) and neonatal distress (p = 0.171), although not statistically significant [46]. In Senegal, Cisse et al., after following women undergoing a CSD over a one-month period, found that the magnitude of neonatal mortality and morbidity was 14.5% vs. 8.7% (with indication), 2.8% vs. 3.2% (discretion), and 12.4% vs. 5.6% (essential) (p <5*10–8) [44]. In one Nepalese study, 94.5% of the newborns had APGAR score ≥6 at one minute and 97.9% at five minutes [49]. For breech and other presentations, CSD tended to be very protective for both the fetal (intepartum without indication: AOR = 0.07, 95%CI = 0.03 – 0.1; intrapartum with indication: AOR = 0.3, 95%CI = 0.2 – 0.4) and the perinatal period while either antepartum (AOR = 0.2, 95%CI = 0.1 – 0.3) or intrapartum (AOR0.3, 0.2–0.4), was associated with improved perinatal outcomes, but also with increased risk of stay in neonatal ICU (2.0, 1.1–3.6); and 2.1, 1.2–3.7, respectively [53]. In Ethiopia, neonate deaths were estimated at 4.49% for emergency CSD [45] and 8.93% of perinatal death of the 392 CSD cases in a Kabul maternity hospital [50]. Sharma & Dhakal found a rather high prevalence of complications (not specified) in newborns through low segment CSD vs. VD (52,1% vs. 28.4%; χ 2 = 26.12, p <0.05) [54]. Torres et al. analyzed deliveries compiled from both public and private providers, including those with the standard care model (“typical” hospitals) and baby-friendly health facilities (“atypical” hospitals) [62].
Torres et al. conducted a national hospital-based cohort and have observed better neonate outcomes for atypical hospitals for early skin-to-skin contact (37.7% vs. 12.8%, p = 0.000); breastfeeding in the first hour after birth (65.8% vs. 11.9%, p = 0.000); rooming-in care during hospitalization (92.2% vs. 34.7%, p = 0.000); exclusive breastfeeding up until discharge (90.3% vs. 56.5%, p = 0.000), and adverse neonatal outcomes (3.2% vs. 2.4%, p = 0.250) [62]. Another study that includes both private and public facilities shows a significant delay in initiating breastfeeding for emergency CSD (aOR 63.85, 95%CI = 34.09–119.60) and elective CSD (aOR34.49, 95%CI = 19.94–59.66) compared to VD [55].
Comparing Outcomes of Elective CSD to Vaginal Delivery
Gonzales et al., when analyzing Peru-wide secondary perinatal data (563,668 deliveries) from 2000 to 2010 from 43 public health facilities, found that, compared to VD, there was a fourfold increase in the prevalency of maternal mortality for elective CSD (OR = 4.45, 95%CI = 3.21–6.18) and as well as for emergency CSD (OR = 4.82 95%%CI = 3.44–6.75) [58]. This mortality rate was higher in low-level hospitals (OR = 5.55 95%CI = 1.46–21.0) than in high-level hospitals OR = 2.37 95% (CI = 1.16 4.0). A multi-country study in seven African countries (Algeria, Angola, DRC, Niger, Nigeria, Uganda, Kenya) contended that high emergency caesarean delivery rates are associated with poor perinatal outcomes (fresh stillbirths: β = 5.119, p < 0.05), severe neonatal morbidity (β = 5.224, p <0.05), while high elective caesarean rates protect fetuses and neonates (fresh stillbirths: β =—6.775, p < 0.05), and neonatal death (β =—6.945, p < 0.05) [48]. Another study in eight Latin American countries (Argentina, Brazil, Cuba, Ecuador, Mexico, Nicaragua, Paraguay, Peru) with 97,095 parturients of public and private health facilities showed that elective CSD leads to low risk for severe maternal morbidity and mortality index (β = 0.277, p = 0.02) compared to intrapartum CSD outcomes (β = 0.355, p = 0.0001) [4]. This was similar for perineal laceration or postpartum fistula (β = (-)0.016, p = 0.2 vs. β = (-)0.016, p = 0.8). For fetal outcomes, the likelihood of death was higher for CSD (β = 0.163, p = 0.01) compared to intrapartum CSD (β = 0.063, p = 0.0001), but lower for neonatal death for elective (elective CSD, β = 0.010, p = 0.9, vs. intrapartum CSD, β = 0.072, p = 0.2).
Several authors have approached the comparison between CSD outcomes and VD postpartum QOL and Quality Adjusted Life Days (QALDs). Thus, Kohler et al. [52] found that the VD group had a higher QOL (0–3 days postpartum: 0.28 vs. 0.57, 3–7 days postpartum: 0.59 vs. 0.81; p < 0.001) and was more likely to report no or slight problems in 4 of 5 health dimensions (mobility, self-care, usual activities, pain or discomfort; p < 0.04) during interviews (1st and 7th days). Similarly, in Nepal, Sharma and Dhakal [49] found that VD led to fewer complications for mothers compared to CSD (39%, vs. 53.5%) and likewise for newborns (28.4% vs. 52.1%).
Intercontinental CSD outcomes comparison
Bauserman et al. conducted a three-continent study in a mix of public and private facilities (India, Pakistan, Kenya, Zambia, Argentina and Guatemala) [64]. The intercontinental comparison resulted in a lower maternal mortality rate (MMR) in Latin America (91/100,000) than in Asia (178/100,000) and an MMR of 125/100,000 in Africa. The relative risk (RR) of maternal death at six weeks was lower for CSD (2.4, 95%CI = 1.8–3.2) compared to assisted VD (3.4 95%CI = 1.8–6.6). In a similar comparative analysis, Souza et al., in dealing with private and public institutions, confirmed the aforementioned differences between continents. In Africa, the outcomes were the worst in all measured dimensions: antepartum CSD without indications: AOR = 71.29, 95%CI = 32.06–158.55, CSD with indications, AOR = 88.61, 95% CI = 74.88–104.86), while this was 2.14, 95%CI = 1.04–4.43 and 8.09, 95%CI = 7.12–9.1, respectively in Asia. In Latin American countries, the findings were the best: 1.94, 95%CI = 0.77–4.9 and 3.04, 95% CI = 2.71–3.41[65].
CSD Outcomes in Public vs. Private Facilities
Studying the LBW-related outcomes and clustering the analysis into private and public university hospitals, Murta et al [60] distinguished, through a multiple logistic regression, that there is a higher risk of LBW among born to women undergoing CSD in private hospitals (AOR = 2.33, 95% CI = 1.19–4.55) than in public ones (OR = 1.4, 95%CI = 0.82 to 2.4). In one study that targeted maternal mortality associated with facility ownership, undergoing CSD in the public sector was 3.3 (95% CI = 2.6–4.3) and was associated with a risk of maternal mortality, although the rate was 32.9% compared to 80.4% in the private sector [59].